Literature DB >> 31391934

Genetic and Environmental Risk Factors for Autoimmune Hepatitis.

Craig Lammert1.   

Abstract

Entities:  

Year:  2019        PMID: 31391934      PMCID: PMC6677013          DOI: 10.1002/cld.798

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN: 2046-2484


× No keyword cloud information.
  10 in total

1.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

Authors:  Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

2.  Family occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study.

Authors:  Lisbet Grønbæk; Hendrik Vilstrup; Lars Pedersen; Kaare Christensen; Peter Jepsen
Journal:  J Hepatol       Date:  2018-06-07       Impact factor: 25.083

3.  Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

Authors:  Ynto S de Boer; Nicole M F van Gerven; Antonie Zwiers; Bart J Verwer; Bart van Hoek; Karel J van Erpecum; Ulrich Beuers; Henk R van Buuren; Joost P H Drenth; Jannie W den Ouden; Robert C Verdonk; Ger H Koek; Johannes T Brouwer; Maureen M J Guichelaar; Jan M Vrolijk; Georg Kraal; Chris J J Mulder; Carin M J van Nieuwkerk; Janett Fischer; Thomas Berg; Felix Stickel; Christoph Sarrazin; Christoph Schramm; Ansgar W Lohse; Christina Weiler-Normann; Markus M Lerch; Matthias Nauck; Henry Völzke; Georg Homuth; Elisabeth Bloemena; Hein W Verspaget; Vinod Kumar; Alexandra Zhernakova; Cisca Wijmenga; Lude Franke; Gerd Bouma
Journal:  Gastroenterology       Date:  2014-04-23       Impact factor: 22.682

4.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

5.  Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.

Authors:  Rui Lin; Lu Zhou; Jie Zhang; Bangmao Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  Autoimmune hepatitis: the role of environmental risk factors: a population-based study.

Authors:  Jing H Ngu; Richard B Gearry; Chris M Frampton; Catherine A M Stedman
Journal:  Hepatol Int       Date:  2013-07-17       Impact factor: 6.047

7.  HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.

Authors:  N M F van Gerven; Y S de Boer; A Zwiers; B J Verwer; J P H Drenth; B van Hoek; K J van Erpecum; U Beuers; H R van Buuren; J W den Ouden; R C Verdonk; G H Koek; J T Brouwer; M M J Guichelaar; J M Vrolijk; M J Coenraad; G Kraal; C J J Mulder; C M J van Nieuwkerk; E Bloemena; H W Verspaget; V Kumar; A Zhernakova; C Wijmenga; L Franke; G Bouma
Journal:  Genes Immun       Date:  2015-01-22       Impact factor: 2.676

Review 8.  Environmental factors in primary biliary cirrhosis.

Authors:  Brian D Juran; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2014-07-24       Impact factor: 6.115

9.  T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8.

Authors:  K E Lundin; H Scott; O Fausa; E Thorsby; L M Sollid
Journal:  Hum Immunol       Date:  1994-12       Impact factor: 2.850

10.  Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.

Authors:  Ynto S de Boer; Andrzej S Kosinski; Thomas J Urban; Zhen Zhao; Nanye Long; Naga Chalasani; David E Kleiner; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2016-06-14       Impact factor: 11.382

  10 in total
  6 in total

1.  A novel insight into the pathophysiology of autoimmune hepatitis: An immune activator mutation in the FLT3 receptor.

Authors:  Muhammed Yuksel; Ayse Armutlu; Farinaz Nazmi; Serdar Ceylaner; Cigdem Arikan
Journal:  Hepatol Forum       Date:  2021-09-07

Review 2.  Human Cytomegalovirus and Autoimmune Diseases: Where Are We?

Authors:  Francesca Gugliesi; Selina Pasquero; Gloria Griffante; Sara Scutera; Camilla Albano; Sergio Fernando Castillo Pacheco; Giuseppe Riva; Valentina Dell'Oste; Matteo Biolatti
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

Review 3.  Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 11.413

4.  Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.

Authors:  Craig Lammert; Sai N Chalasani; Kelsey Green; Elizabeth Atkinson; Bryan McCauley; Konstantinos N Lazaridis
Journal:  Dig Dis Sci       Date:  2021-04-30       Impact factor: 3.487

Review 5.  Selected transgenic murine models of human autoimmune liver diseases.

Authors:  Katarzyna Trzos; Natalia Pydyn; Jolanta Jura; Jerzy Kotlinowski
Journal:  Pharmacol Rep       Date:  2022-01-15       Impact factor: 3.024

6.  Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis.

Authors:  Sai Chalasani; Karan Mathur; Nicole Shammas; Eric Orman; Raj Vuppalanchi; Craig Lammert
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.